Advertisement

Advertisement

2022 Community Oncology Alliance Annual Meeting

Multiple Myeloma

By Caroline Helwick  / June 10, 2022  / 2022 Community Oncology Alliance Annual Meeting

Multiple Myeloma: Treatment Conundrums

The availability of numerous new agents for treating multiple myeloma has created some “conundrums” for clinicians, said Sergio Giralt, MD, Deputy Head of the Division of Hematologic Malignancies at M...

Issues in Oncology

By Chase Doyle  / May 25, 2022  / 2022 Community Oncology Alliance Annual Meeting

The Future of Community Oncology Practice

Although community oncology practice may have been changing before the COVID-19 pandemic, it amplified industry trends. At the 2022 Community Oncology Alliance’s Community Oncology Conference, a panel...

Advertisement

Advertisement



Aug
10
Today In Oncology
Increased Utilization of SBRT Has Decreased Treatment Disparities for Early-Stage NSCLC
Study Finds Adding Tremelimumab and Durvalumab to Chemotherapy Improves Overall Survival in Metastatic NSCLC Regardless of KRAS/STK11/KEAP1 Mutations
Addition of Transarterial Chemoembolization to Lenvatinib in First-Line Treatment of Advanced Hepatocellular Carcinoma
An Early Encounter With Cancer Sets a Path to a Career in Oncology Research
Long-Term Regional Disease Control With Sentinel Lymph Node Biopsy in Patients With Melanoma
View More 
Advertisement
© 2022 HSP News Service, L.L.C.
Designed by Harborside